PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes

Biomaterials

Volumn 33, Issue 31, 2012, Pages 7785-7793

  Locke, Landon W ^a   Mayo, Marty W ^b   Yoo, Alexander D ^b   Williams, Mark B ^a,b,c   Berr, Stuart S ^a,b  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c University of Virginia   (United States)

Author keywords

Animal model; Liposome; Macrophage; Molecular imaging; Positron emission tomography

Indexed keywords

ANIMAL MODEL; ANTI-TUMOR ACTIVITIES; BLOOD VESSEL GROWTH; BREAK DOWN; CANCER CELLS; CYTOKINES; EXTRACELLULAR MATRICES; FLUORESCENT DYES; IMAGING AGENT; IN-VIVO; LUNG CANCER; MANNOSE RECEPTORS; MANNOSYLATED LIPOSOMES; MOUSE MODELS; PET IMAGES; PET IMAGING; SCAVENGER RECEPTOR; T CELLS; THERAPEUTIC AGENTS; TUMOR MICROENVIRONMENT;

BIOLOGICAL ORGANS; BLOOD VESSELS; DISEASES; FLUORESCENCE MICROSCOPY; LIPID BILAYERS; LIPOSOMES; MAMMALS; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; TUMORS;

MACROPHAGES;

COPPER 64; CYTOKINE; FLUORESCENT DYE; LIPOSOME; MANNOSE; MANNOSE RECEPTOR; SCAVENGER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; LIPID BILAYER; LUNG ADENOCARCINOMA; LUNG CANCER; MACROPHAGE; METASTASIS; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT;

ANIMALS; COPPER RADIOISOTOPES; FEMALE; LIPOSOMES; LUNG NEOPLASMS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MANNOSE; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SPIN LABELS; URETHANE;

ANIMALIA;

EID: 84865192265     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.022     Document Type: Article

References (40)

1. Marin L., Colombo P., Bebawy M., Young P.M., Traini D., Marin L., et al. Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Expert Opin Drug Deliv 2011, 8(9):1205-1220.
2. Murphy B.S., Bush H.M., Sun dareshan V., Davis C., Hagadone J., Cory T.J., et al. Characterization of macrophage activation states in patients with cystic fibrosis. J Cyst Fibros 2010, 9(5):314-322.
3. Allavena P., Sica A., Solinas G., Porta C., Mantovani A., Allavena P., et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66(1):1-9.
4. Bingle L., Brown N.J., Lewis C.E., Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196(3):254-265.
5. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E., Murdoch C., Muthana M., et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008, 8(8):618-631.
6. Siveen K.S., Kuttan G., Siveen K.S., Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009, 123(2):97-102.
7. Robinson S.C., Scott K.A., Wilson J.L., Thompson R.G., Proudfoot A.E., Balkwill F.R., et al. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 2003, 63(23):8360-8365.
8. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A., et al. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006, 95(3):272-281.
9. Banciu M., Metselaar J.M., Schiffelers R.M., Storm G., Banciu M., Metselaar J.M., et al. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia 2008, 10(2):108-117.
10. Zhang B., Yao G., Zhang Y., Gao J., Yang B., Rao Z., et al. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo) 2011, 66(11):1879-1886.
11. Pollard J.W., Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4(1):71-78.
12. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L., Weissleder R., et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23(11):1418-1423.
13. Leimgruber A., Berger C., Cortez-Retamozo V., Etzrodt M., Newton A.P., Waterman P., et al. Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia 2002, 11(5):459-468.
14. Melancon M.P., Lu W., Huang Q., Thapa P., Zhou D., Ng C., et al. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813. Biomaterials 2010, 31(25):6567-6573.
15. Allavena P., Chieppa M., Bianchi G., Solinas G., Fabbri M., Laskarin G., et al. Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 2010, 2010:547179.
16. Redente E.F., Orlicky D.J., Bouchard R.J., Malkinson A.M., Redente E.F., Orlicky D.J., et al. Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am J Pathol 2007, 170(2):693-708.
17. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A., Mantovani A., et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23(11):549-555.
18. Lee S.J., Evers S., Roeder D., Parlow A.F., Risteli J., Risteli L., et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 2002, 295(5561):1898-1901.
19. McGreal E.P., Martinez-Pomares L., Gordon S., McGreal E.P., Martinez-Pomares L., Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004, 41(11):1109-1121.
20. Stathopoulos G.T., Sherrill T.P., Cheng D.S., Scoggins R.M., Han W., Polosukhin V.V., et al. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A 2007, 104(47):18514-18519.
21. Austyn J.M., Gordon S., Austyn J.M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11(10):805-815.
22. Petersen A.L., Binderup T., Rasmussen P., Henriksen J.R., Elema D.R., Kjaer A., et al. 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 2011, 32(9):2334-2341.
23. Yamazaki T., Nagata K., Kobayashi Y., Yamazaki T., Nagata K., Kobayashi Y. Cytokine production by M-CSF- and GM-CSF-induced mouse bone marrow-derived macrophages upon coculturing with late apoptotic cells. Cell Immunol 2008, 251(2):124-130.
24. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G., et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29(43):13435-13444.
25. Mosser D.M., Edwards J.P., Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8(12):958-969.
26. Litzinger D.C., Huang L., Litzinger D.C., Huang L. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim Biophys Acta 1992, 1127(3):249-254.
27. Loening A.M., Gambhir S.S., Loening A.M., Gambhir S.S. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003, 2(3):131-137.
28. Matsui M., Shimizu Y., Kodera Y., Kondo E., Ikehara Y., Nakanishi H., et al. Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci 2010, 101(7):1670-1677.
29. Wijagkanalan W., Higuchi Y., Kawakami S., Teshima M., Sasaki H., Hashida M., et al. Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model. Mol Pharmacol 2008, 74(5):1183-1192.
30. Wijagkanalan W., Kawakami S., Takenaga M., Igarashi R., Yamashita F., Hashida M., et al. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 2008, 125(2):121-130.
31. Bauer A.K., Cho H.Y., Miller-Degraff L., Walker C., Helms K., Fostel J., et al. Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS ONE 2011, 6(10):e26590.
32. Redente E.F., Dwyer-Nield L.D., Merrick D.T., Raina K., Agarwal R., Pao W., et al. Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol 2010, 176(6):2972-2985.
33. Shimkin M.B., Stoner G.D., Shimkin M.B., Stoner G.D. Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res 1975, 21:1-58.
34. Kojima N., Biao L., Nakayama T., Ishii M., Ikehara Y., Tsujimura K., et al. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. J Control Release 2008, 129(1):26-32.
35. Duluc D., Corvaisier M., Blanchard S., Catala L., Descamps P., Gamelin E., et al. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 2009, 125(2):367-373.
36. Raveh D., Kruskal B.A., Farland J., Ezekowitz R.A., Raveh D., Kruskal B.A., et al. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J Leukoc Biol 1998, 64(1):108-113.
37. Srinivas S.M., Dhurairaj T., Basu S., Bural G., Surti S., Alavi A., et al. A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 2009, 23(4):341-348.
38. Branco SS, Almeida P. Respiratory motion modeling in small animal PET using GATE. NSS '08. IEEE Nucl Sci Symp Conf Rec 2012; 2008.
39. Singodia D., Verma A., Verma R.K., Mishra P.R. Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomed Nanotechnol Biol Med 2012, 8(4):468-477.
40. Ishida T., Harashima H., Kiwada H., Ishida T., Harashima H., Kiwada H. Liposome clearance. Biosci Rep 2002, 22(2):197-224.